Paul Ian Cross

London

Science Writer, Author, and Educator at Freelance

Featured in: Favicon

aol.com

medicalnewstoday.com Favicon

iflscience.com Favicon

newsbreak.com Favicon

healthgrades.com Favicon

southfloridareporter.com

Articles

HIV drugs may offer ‘significant’ protection

3 days ago | medicalnewstoday.com | Paul Ian Cross

Share on PinterestResearchers at UVA Health have found that a class of HIV drugs called nucleotide reverse transcriptase inhibitors (NRTIs) may significantly reduce the risk of developing Alzheimer’s disease. Their large-scale analysis of United States health insurance data revealed that patients taking these medications had up to a 13% lower risk of Alzheimer’s disease each year.
Simple urine test may help with early detection

1 week ago | medicalnewstoday.com | Paul Ian Cross

Share on PinterestEarly detection of prostate cancer remains a major clinical challenge due to the lack of reliable biomarkers, despite the disease being highly treatable when caught in its early stages. Now, researchers have identified a new set of urine-based biomarkers that can accurately detect both the presence and severity of prostate cancer. The study combines artificial intelligence with detailed genetic analysis and could potentially offer an alternative to current PSA testing.
Mounjaro can help maintain long-term weight loss

3 weeks ago | medicalnewstoday.com | Paul Ian Cross

Share on PinterestAccording to a new study, a once-weekly dose of tirzepatide can lead to significant, sustained weight loss for up to 3 years in adults with overweight or obesity who do not have diabetes. The findings build on earlier results from the SURMOUNT-1 trial and suggest that treatment responses may vary based on factors such as sex and the presence of obesity-related conditions. Researchers also identified patterns in how participants lost weight over time.
Study finds keys to minimize muscle loss from GLP-1 drugs

1 month ago | medicalnewstoday.com | Paul Ian Cross

Share on PinterestGLP-1 drugs have helped people successfully achieve and maintain weight loss; however, losing muscle has been a significant concern. New research suggests that weight loss treatments using GLP-1 and dual GLP-1/GIP receptor agonists can lead to significant fat loss while still maintaining lean muscle mass. The study found that strength training and enough protein were key to keeping muscle while losing weight, as well as getting guidance from an obesity medicine specialist.
Skipping screenings may increase death risk by 45%

1 month ago | medicalnewstoday.com | Paul Ian Cross

Share on PinterestMen who often miss their prostate cancer screening appointments are much more likely to die from the disease, according to new findings. The analysis, based on 20 years of data from over 160,000 men across seven European countries, highlights a newly identified high-risk group often overlooked in national screening efforts.
Treating sleep apnea may help lower risk

2 months ago | medicalnewstoday.com | Paul Ian Cross

Share on PinterestPeople with obstructive sleep apnea may have a higher risk of developing Parkinson’s disease, but early use of continuous positive airway pressure (CPAP) therapy could help lower that risk. A large-scale study of veterans found that those who began CPAP treatment within 2 years of their diagnosis had fewer cases of Parkinson’s compared to those who delayed or did not use the therapy.
CPAP therapy for sleep apnea may help lower Parkinson's risk

2 months ago | resources.healthgrades.com | Paul Ian Cross

People with obstructive sleep apnea may have a higher risk of developing Parkinson’s disease, but early use of continuous positive airway pressure (CPAP) therapy could help lower that risk. A large-scale study of veterans found that those who began CPAP treatment within 2 years of their diagnosis had fewer cases of Parkinson’s compared to those who delayed or did not use the therapy.
Could a broccoli sprout compound lower blood sugar?

2 months ago | resources.healthgrades.com | Paul Ian Cross

Researchers from the University of Gothenburg in Sweden have found that sulforaphane, a compound found in broccoli sprouts, may help lower blood sugar levels in people with prediabetes. The study found that the compound works better for people with certain metabolism types and a specific gut bacteria. While this suggests sulforaphane could be used for more personalised treatment, experts stress that a healthy diet and regular exercise are still key to managing prediabetes.
Broccoli sprout compound may lower blood sugar

2 months ago | medicalnewstoday.com | Paul Ian Cross

Share on PinterestResearchers from the University of Gothenburg in Sweden have found that sulforaphane, a compound found in broccoli sprouts, may help lower blood sugar levels in people with prediabetes. The study found that the compound works better for people with certain metabolism types and a specific gut bacteria. While this suggests sulforaphane could be used for more personalised treatment, experts stress that a healthy diet and regular exercise are still key to managing prediabetes.
Daily omega-3 could help prolong health span

Feb 7, 2025 | medicalnewstoday.com | Paul Ian Cross

Share on PinterestA new study suggests that omega-3 and vitamin D supplements, when combined with regular exercise, may help slow biological aging by several months over a 3-year period. Researchers analysed data from the DO-HEALTH trial, which tracked over 700 older adults and found that those who followed this regimen experienced measurable benefits at the molecular level.